RhumbLine Advisers’s Provention Bio, Inc. Common Stock PRVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-86,095
| Closed | -$2.08M | – | 4416 |
|
|
2023
Q1 | $2.08M | Buy |
86,095
+4,804
| +6% | +$116K | ﹤0.01% | 1788 |
|
|
2022
Q4 | $859K | Buy |
81,291
+6,427
| +9% | +$67.9K | ﹤0.01% | 2215 |
|
|
2022
Q3 | $337K | Buy |
74,864
+8,116
| +12% | +$36.5K | ﹤0.01% | 2682 |
|
|
2022
Q2 | $267K | Sell |
66,748
-4,190
| -6% | -$16.8K | ﹤0.01% | 2818 |
|
|
2022
Q1 | $519K | Sell |
70,938
-6,728
| -9% | -$49.2K | ﹤0.01% | 2409 |
|
|
2021
Q4 | $436K | Buy |
77,666
+351
| +0.5% | +$1.97K | ﹤0.01% | 2568 |
|
|
2021
Q3 | $495K | Buy |
77,315
+1,238
| +2% | +$7.93K | ﹤0.01% | 2547 |
|
|
2021
Q2 | $641K | Buy |
76,077
+21,338
| +39% | +$180K | ﹤0.01% | 2442 |
|
|
2021
Q1 | $574K | Sell |
54,739
-1,015
| -2% | -$10.6K | ﹤0.01% | 2427 |
|
|
2020
Q4 | $944K | Buy |
55,754
+4,967
| +10% | +$84.1K | ﹤0.01% | 2159 |
|
|
2020
Q3 | $652K | Sell |
50,787
-5,985
| -11% | -$76.8K | ﹤0.01% | 2169 |
|
|
2020
Q2 | $801K | Buy |
+56,772
| New | +$801K | ﹤0.01% | 2134 |
|